Andriy Marusyk

23PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologySpeciation and extinctionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 29, 2026
Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

|May 22, 2026
Evolutionary Antifragile Therapy Is a Treatment Strategy to Suppress Drug Resistance by Exploiting Dose-Response Convexity.

|May 22, 2026
Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in KRASG12C -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumors.

|Dec 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK-driven lung cancer by concurrent integrin and MET signaling.

Qianqian Hu, Lily L Remsing Rix, Bina Desai

|Oct 30, 2025
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer.

Hitendra S Solanki, Harshit Shah, Denis Imbody

|Aug 09, 2025
The role of environmentally mediated drug resistance in facilitating the spatial distribution of residual disease.

Amy Milne, Andriy Marusyk, Philip K Maini

Pageof 4

Frequent Collaborators

9 joint publications

Bina Desai

9 joint publications

Daria Miroshnychenko

7 joint publications

Jacob Scott

6 joint publications

David Basanta